Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Motus GI Holdings, Inc. (MOTS)

1.01   0 (0%) 01-27 16:00
Open: 1.01 Pre. Close: 1.01
High: 1.035 Low: 0.98
Volume: 41,910 Market Cap: 5(M)

Technical analysis

as of: 2023-01-27 4:46:22 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.34     One year: 1.56
Support: Support1: 0.85    Support2: 0.68
Resistance: Resistance1: 1.14    Resistance2: 1.34
Pivot: 0.97
Moving Average: MA(5): 1     MA(20): 0.94
MA(100): 1.69     MA(250): 4.05
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 58     %D(3): 58.9
RSI: RSI(14): 48.4
52-week: High: 13  Low: 0.25
Average Vol(K): 3-Month: 186 (K)  10-Days: 109 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MOTS ] has closed below upper band by 26.5%. Bollinger Bands are 80.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.04 - 1.04 1.04 - 1.05
Low: 0.97 - 0.97 0.97 - 0.98
Close: 1 - 1.01 1.01 - 1.02

Company Description

Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

Headline News

Sat, 28 Jan 2023
Eight most confusing MOT questions answered - including when an MOT is due in - Express

Sat, 28 Jan 2023
Obituary and funeral service: Martha 'Mot' Hornick, 75, of Loganville - Monroe Local News

Sat, 28 Jan 2023
Five cars with the highest MOT pass rate for new drivers - including Peugeot and Skoda - Express

Fri, 27 Jan 2023
Do electric cars need yearly MOTs as vehicle ownership booms - Coventry Live

Thu, 26 Jan 2023
Challenge to safety: Government proposes switch to MoTs every two years - This is Money

Mon, 23 Jan 2023
MOT change proposals: the industry reacts - FleetPoint

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 5 (M)
% Held by Insiders 4.48e+006 (%)
% Held by Institutions 2.5 (%)
Shares Short 221 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.788e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -3
Return on Assets (ttm) 157.8
Return on Equity (ttm) -51.7
Qtrly Rev. Growth 582000
Gross Profit (p.s.) 53.11
Sales Per Share -148.31
EBITDA (p.s.) -127322
Qtrly Earnings Growth -0.4
Operating Cash Flow 0 (M)
Levered Free Cash Flow -17 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 7.39

Stock Dividends

Dividend 0
Forward Dividend 200900
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.